Webinar—Mastering Ophthalmic Drug Formulation and Testing: Strategies for Success скачать в хорошем качестве

Webinar—Mastering Ophthalmic Drug Formulation and Testing: Strategies for Success

Navigate the discussion with these timestamps: 00:00—Introduction to Ocular Therapeutics 00:40—Agenda 02:40—Recent Innovations in Ophthalmic Medications 05:36—Challenges in Ocular Drug Delivery 11:06—Pros and Cons of Ophthalmic Dosage Forms 12:38—Nanotechnology in Ocular Therapeutics 17:47—Formulation Strategies for Retention Time 19:47—Manufacturing Considerations for Ocular Drugs 25:14—Conclusion and Q&A Session 25:21—Q1: What are the cost differences between aseptic manufacturing and terminal sterilization routes? 28:07—Q2: Is there anything that you do after the sterilization event to ensure that the product is still maintained and has not degraded at all? 28:57—Q3: Are you seeing more preservative-free ophthalmic formulations as the trend continues to grow? Join industry experts to explore the intricacies of formulation development and analytical testing of ophthalmic drugs, including using a Quality by Design approach, nanosuspensions, and the latest analytical testing methodologies. This webinar on ophthalmic drug formulation, manufacturing, and testing will equip viewers with critical knowledge to navigate the competitive ophthalmic drug market and overcome the complexities of creating effective therapies. It will provide pharmaceutical and biotech companies with in-depth knowledge of developing complex dosage forms, utilizing high-performance excipients, and managing technical and regulatory challenges to ensure successful production. Additionally, viewers will gain valuable insights into GMP-compliant manufacturing practices, from small to large-scale production, and discover the importance of rigorous testing procedures for quality assurance, including microbiological and environmental monitoring. 𝗔𝘁𝘁𝗲𝗻𝗱𝗲𝗲𝘀 𝘄𝗶𝗹𝗹 𝗹𝗲𝗮𝗿𝗻 𝗮𝗯𝗼𝘂𝘁: • advanced formulation techniques for ophthalmic drug development; • analytical testing processes used to ensure the quality, safety, and effectiveness of ophthalmic products for upcoming preclinical and clinical trials. 𝗪𝗵𝗼 𝗺𝗮𝘆 𝘁𝗵𝗶𝘀 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁? • Pharmaceutical and biotech professionals • Ophthalmic drug development companies • Toxicologists • Study directors • Clinicians • Research consultants 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: Andrew Buis, Senior Formulation Scientist, Altasciences Anthony James, Executive Director, Business Development, Altasciences